Picture of Newbury Pharmaceuticals AB logo

NEWBRY — Newbury Pharmaceuticals AB News Story

0.000.00%
se flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap

Brief: Newbury Pharmaceuticals Q2 EBITDA Loss Widens To SEK 4.6 Mln

April 12 (Reuters) - Newbury Pharmaceuticals AB
 NEWBRY.ST :
    * Q2 NET REVENUE WAS 1 501 (302) TKR
    * Q2 EBITDA WAS -4 550 (-3 382) TKR

Source text for Eikon:  ID:nMFNb1Crrb 
Further company coverage:  NEWBRY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Newbury Pharmaceuticals AB

See all news